ATARA BIOTHERAPEUTICS, INC. (ATRA) Free cash flow 2016–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$50.9MFY2025 · since FY2016: -$63.0M → -$50.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.9M | +26.1% |
| FY2024 | -$69.0M | +64.5% |
| FY2023 | -$194.2M | +29.3% |
| FY2022 | -$274.6M | -18.8% |
| FY2021 | -$231.1M | -24.7% |
| FY2020 | -$185.3M | +23.2% |
| FY2019 | -$241.4M | -11.9% |
| FY2018 | -$215.7M | -100.2% |
| FY2017 | -$107.7M | -70.9% |
| FY2016 | -$63.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice